IMDX
Insight Molecular Diagnostics Inc.
2.70$
-3.3%
vs. previous close
Closing price · As of: Nov 4, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Insight Molecular Diagnostics Inc. (IMDX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/21/2026 | Current report (8-K) | Insight Molecular Diagnostics Inc. (IMDX): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 08/10/2026 | Current report (8-K) | Insight Molecular Diagnostics Inc. (IMDX): Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.